BCAL Diagnostics LimitedASX: BDX

Investor Presentation - Transforming Cancer Detection

Oct 5, 2026 at 7:15 PM EDT · Issued by BCAL Diagnostics Limited via ASX

Filed with ASX · Oct 5, 2026 at 7:15 PM EDT · 14 pages · English

On 6ix: 6ix.com/news/investor-presentation-transforming-cancer-detection

Release

Transforming early cancer detection with novel blood testsINVESTOR PRESENTATIONAnne-Louise ArnettChief Executive OfficerMST Access Biotech & Healthcare WebinarOctober 2026ASX:BDXBCAL Diagnostics | MST Access Biotech & Healthcare | October 2026BCAL is building an Australian platform for earlier...

BCAL Diagnostics Limited on 6ix

Earlier from BCAL Diagnostics

Change in substantial holdingOct 1
BREASTESTplus 2 clinically validatedSep 29
BCAL Introduces Avantect Multi-Cancer Early Detection TestSep 22
Letter to Shareholders re Annual General MeetingSep 17
Notice of Annual General Meeting/Proxy FormSep 17

Later from BCAL Diagnostics

Letter to Genetic Signatures Ltd ShareholdersOct 14
GSS: Response to Media Speculation & BCAL letter to GSSOct 16
BREASTESTplus Research Presented at Lipidomic ConferenceOct 18
AGM 2026 PresentationOct 18
Results of MeetingOct 18

All BCAL Diagnostics news releases

Follow BCAL Diagnostics into a list and get an email when it puts out news.

Follow BCAL Diagnostics